Venooclussive disease and systemic sclerosis.

Med Clin (Barc)

Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Complejo Hospitalario Universitario de Granada, Granada, España.

Published: October 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2017.04.029DOI Listing

Publication Analysis

Top Keywords

venooclussive disease
4
disease systemic
4
systemic sclerosis
4
venooclussive
1
systemic
1
sclerosis
1

Similar Publications

Objective: To evaluate the therapeutic efficacy (in terms of overall survival [OS] and progression-free survival [PFS]) of a high-dose chemotherapy protocol including four drugs and peripheral stem cell rescue (PSCR) plus posttransplant G-CSF (filgrastim) in disseminated breast cancer patients.

Patients And Methods: Fifty-three metastatic breast cancer patients were treated with a four-drug program of high-dose chemotherapy including cyclophosphamide (6 g/m2), thiotepa (500 mg/m2), carboplatin (800-1,600 mg/m2) and mitoxantrone (20-60 mg/m2) with autologous peripheral blood progenitor cell support followed by filgrastim. Most cases (92%) had previously received conventional induction chemotherapy with anthracycline-containing combinations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!